Transgenic toll-like receptor 9 (TLR9) mice
View Patent ↗The present invention provides a receptor protein specifically recognizing bacterial DNA having an unmethylated CpG sequence, a genomic DNA encoding it, an experimental animal model useful for examining responsiveness of a host immune cell against a bacterial infectious disease. DNA encoding a receptor protein specifically recognizing bacterial DNA having an unmethylated CpG sequence is screened by BLAST search, a number of EST clones having high homology with various TLRs is screened, these clones are used as a probe to isolate a full-length cDNA from mouse macrophage cDNA library, and the sequence of bases of the cDNA is analyzed to confirm that it is TLR9 comprising a conserved regions such as LRR and TIR regions, and then a knockout mouse is produced to confirm that TLR9 is a receptor protein of oligonucleotides having an unmethylated CpG sequence of bacterial DNA.
1. A transgenic mouse whose genome comprises a homozygous inactivation of the Toll-like Receptor 9 (TLR9) gene such that no functional N-terminal fragment of TLR9 is produced; said TLR9 gene encodes a polypeptide that recognizes CpG oligodeoxynucleotide (ODN), wherein macrophages of said mouse exhibit decreased responsiveness to CpG ODN.
2. A cell obtained from the transgenic mouse according to claim 1 .